From: Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study
Rethymnon %
Hania %
Difference in prevalence
95%CI
Males
HBsAg
2.03
2.80
-0.008
(-0.013, -0.003)*
anti-HCV
4.70
2.73
0.020
(0.011, 0.028)**
Females
0.94
1.73
(-0.012, 0.004)**
Anti-HCV
5.64
1.97
0.037
(0.027, 0.046)**